This company has been marked as potentially delisted and may not be actively trading. Digirad (DRAD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DRAD vs. POCI, NXL, QTI, NRXS, IRIX, STRR, MOVE, TIVC, NDRA, and NUWEShould you be buying Digirad stock or one of its competitors? The main competitors of Digirad include Precision Optics (POCI), Nexalin Technology (NXL), QT Imaging (QTI), NeurAxis (NRXS), IRIDEX (IRIX), Star Equity (STRR), Movano (MOVE), Tivic Health Systems (TIVC), ENDRA Life Sciences (NDRA), and Nuwellis (NUWE). Digirad vs. Its Competitors Precision Optics Nexalin Technology QT Imaging NeurAxis IRIDEX Star Equity Movano Tivic Health Systems ENDRA Life Sciences Nuwellis Digirad (NASDAQ:DRAD) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking and earnings. Is DRAD or POCI more profitable? Digirad has a net margin of -5.32% compared to Precision Optics' net margin of -21.46%. Digirad's return on equity of -3.75% beat Precision Optics' return on equity.Company Net Margins Return on Equity Return on Assets Digirad-5.32% -3.75% -0.85% Precision Optics -21.46%-39.17%-22.93% Do institutionals and insiders believe in DRAD or POCI? 11.4% of Digirad shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 12.5% of Digirad shares are owned by company insiders. Comparatively, 16.3% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk & volatility, DRAD or POCI? Digirad has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500. Does the media refer more to DRAD or POCI? In the previous week, Precision Optics had 2 more articles in the media than Digirad. MarketBeat recorded 2 mentions for Precision Optics and 0 mentions for Digirad. Precision Optics' average media sentiment score of 0.43 beat Digirad's score of 0.00 indicating that Precision Optics is being referred to more favorably in the news media. Company Overall Sentiment Digirad Neutral Precision Optics Neutral Which has stronger earnings & valuation, DRAD or POCI? Precision Optics has lower revenue, but higher earnings than Digirad. Digirad is trading at a lower price-to-earnings ratio than Precision Optics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDigirad$114.18M0.08-$4.63M-$0.35-5.66Precision Optics$17.63M2.03-$2.95M-$0.89-5.25 Does the MarketBeat Community favor DRAD or POCI? Digirad received 318 more outperform votes than Precision Optics when rated by MarketBeat users. Likewise, 70.35% of users gave Digirad an outperform vote while only 0.00% of users gave Precision Optics an outperform vote. CompanyUnderperformOutperformDigiradOutperform Votes31870.35% Underperform Votes13429.65% Precision OpticsOutperform VotesNo VotesUnderperform Votes2100.00% SummaryDigirad beats Precision Optics on 8 of the 15 factors compared between the two stocks. Get Digirad News Delivered to You Automatically Sign up to receive the latest news and ratings for DRAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DRAD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRAD vs. The Competition Export to ExcelMetricDigiradElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.43M$3.33B$5.57B$8.50BDividend Yield83.65%1.72%5.27%4.17%P/E Ratio-0.6319.1726.7519.65Price / Sales0.08195.99403.98152.07Price / Cash0.6944.0938.2534.64Price / Book0.193.816.964.59Net Income-$4.63M$94.03M$3.23B$248.23M Digirad Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRADDigiradN/A$1.98-2.9%N/A+138.6%$9.43M$114.18M-0.63618POCIPrecision Optics0.296 of 5 stars$4.68+0.9%N/A-23.1%$35.88M$17.63M-7.3180Short Interest ↑Gap DownNXLNexalin Technology2.339 of 5 stars$1.26-1.2%$5.00+298.4%+27.9%$21.56M$131.07K-1.963QTIQT ImagingN/A$0.79flatN/A+11.3%$21.44M$4.00M0.00N/AGap DownNRXSNeurAxis0.9411 of 5 stars$2.43-8.6%N/A-22.9%$17.54M$2.93M-1.3219Short Interest ↑IRIXIRIDEX0.4857 of 5 stars$0.95-4.2%N/A-55.2%$15.87M$48.80M-1.41120News CoverageShort Interest ↑STRRStar Equity2.8251 of 5 stars$2.10flat$5.00+138.1%-51.1%$6.74M$57.17M-0.82460Short Interest ↑MOVEMovano2.1113 of 5 stars$0.75+0.3%$30.00+3,894.7%-89.2%$5.29M$1.01M-0.1530Trending NewsShort Interest ↑Gap UpHigh Trading VolumeTIVCTivic Health Systems0.4833 of 5 stars$3.90+1.0%N/A-46.0%$3.42M$516K0.0010NDRAENDRA Life Sciences2.7172 of 5 stars$3.49-0.6%$50.00+1,332.7%-100.0%$2.58MN/A0.0020Gap DownNUWENuwellis3.0766 of 5 stars$0.23+1.8%$17.00+7,158.8%-95.9%$1.02M$8.79M0.0070High Trading Volume Related Companies and Tools Related Companies Precision Optics Competitors Nexalin Technology Competitors QT Imaging Competitors NeurAxis Competitors IRIDEX Competitors Star Equity Competitors Movano Competitors Tivic Health Systems Competitors ENDRA Life Sciences Competitors Nuwellis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRAD) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Digirad Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Digirad With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
